Clinical Trials List
Protocol NumberJ5Q-OX-JRDA
Active
2024-11-29 - 2029-03-02
Phase I
Recruiting2
ICD-10C76.0
Malignant neoplasm of head, face and neck
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9195.0
Malignant neoplasm of other and ill-defined sites of head, face and neck
-
Trial Applicant
MEDPACE TAIWAN LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳尚俊 無
- 徐偉勛 無
- SHIH-HUNG YANG 無
- 廖唯昱 無
- Chong-Jen Yu 無
- YEN-TING LIN 無
- 許嘉林 無
- 楊景堯 無
- 蔡子修 無
- CHAO-CHI HO CHAO-CHI HO 無
- Jih-Hsiang Lee 無
- 梁逸歆 無
- James Chih-Hsin Yang 無
- 廖斌志 無
- 吳宗哲 無
- JIN-YUAN SHIH 無
- 陳國興 無
- Kun-Huei Yeh 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
80 participants
-
Global
750 participants
